SZN-043, AN R-SPONDIN MIMETIC IN DEVELOPMENT FOR THE TREATMENT OF LIVER DISEASE, DEMONSTRATES A STRONG SAFETY PROFILE IN NONCLINICAL TOXICOLOGY STUDIES

Jay Tibbitts  1     Maureen Newman  1     Peter Stathis  1     Anh Diep  1     Geertrui Vanhove  1    
1 Surrozen Inc, South San Francisco, United States

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing